Pei‐Jer Chen

57.8k total citations · 6 hit papers
836 papers, 38.4k citations indexed

About

Pei‐Jer Chen is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Pei‐Jer Chen has authored 836 papers receiving a total of 38.4k indexed citations (citations by other indexed papers that have themselves been cited), including 503 papers in Epidemiology, 497 papers in Hepatology and 127 papers in Molecular Biology. Recurrent topics in Pei‐Jer Chen's work include Hepatitis B Virus Studies (425 papers), Hepatitis C virus research (420 papers) and Liver Disease Diagnosis and Treatment (318 papers). Pei‐Jer Chen is often cited by papers focused on Hepatitis B Virus Studies (425 papers), Hepatitis C virus research (420 papers) and Liver Disease Diagnosis and Treatment (318 papers). Pei‐Jer Chen collaborates with scholars based in Taiwan, United States and China. Pei‐Jer Chen's co-authors include Ding‐Shinn Chen, Jia‐Horng Kao, Chun‐Jen Liu, Ming–Yang Lai, Shiou‐Hwei Yeh, Chen‐Hua Liu, Kuen‐Feng Chen, Ann‐Lii Cheng, Tung‐Hung Su and Hung‐Chih Yang and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Pei‐Jer Chen

813 papers receiving 37.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hepatitis B e Antigen and the Risk of Hepatocellular Carcinoma

2002 926 citations Hwai‐I Yang, Yun‐Fan Liaw et al. profile →
Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study

2015 879 citations Pei‐Jer Chen, Morris Sherman et al. profile →
Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B

2000 784 citations Jia‐Horng Kao, Pei‐Jer Chen et al. Gastroenterology profile →
Linifanib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: Results of a Randomized Phase III Trial

2014 465 citations Pei‐Jer Chen et al. Journal of Clinical Oncology profile →
Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score

2011 457 citations Hwai‐I Yang, Kwang‐Hyub Han et al. profile →
High Levels of Hepatitis B Surface Antigen Increase Risk of Hepatocellular Carcinoma in Patients With Low HBV Load

2012 415 citations Tai‐Chung Tseng, Chun‐Jen Liu et al. Gastroenterology profile →

Peers

Countries citing papers authored by Pei‐Jer Chen

Since Specialization

Citations

This map shows the geographic impact of Pei‐Jer Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pei‐Jer Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pei‐Jer Chen more than expected).

Fields of papers citing papers by Pei‐Jer Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pei‐Jer Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pei‐Jer Chen. The network helps show where Pei‐Jer Chen may publish in the future.

Co-authorship network of co-authors of Pei‐Jer Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Pei‐Jer Chen. A scholar is included among the top collaborators of Pei‐Jer Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pei‐Jer Chen. Pei‐Jer Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Global burden of vision impairment due to smoking-related cataract: A descriptive study of spatiotemporal trends based on GBD secondary data and projections to 2050 2025 ·Tobacco Induced Diseases ·Pei‐Jer Chen, (unknown), (unknown), (unknown), Andrzej Grzybowski, (unknown)	0
2	Challenges for hepatitis B control in Asia‐Pacific areas: Consolidating vaccination and rolling‐out antiviral therapies 2024 ·Journal of Gastroenterology and Hepatology ·Pei‐Jer Chen	0
3	Flexible Electrodes for Aqueous Hybrid Supercapacitors: Recent Advances and Future Prospects 2024 ·Electrochemical Energy Reviews ·Siyu Liu, Juan Yang, Pei‐Jer Chen, Man Wang, Songjie He, Lu Wang, Jieshan Qiu	34
4	Synergistic efficacy of telomerase-specific oncolytic adenoviral therapy and histone deacetylase inhibition in human hepatocellular carcinoma 2023 ·Cancer Letters ·Zhong‐Zhe Lin, Mickey C.‐T. Hu, Chiun Hsu, Yao‐Ming Wu, Yen‐Shen Lu, Ja‐an Annie Ho, Shiou‐Hwei Yeh, Pei‐Jer Chen, Ann‐Lii Cheng	7
5	Self‐reported oral health status, edentulism and all‐cause mortality risk in 12 809 Australian older adults: a prospective cohort study 2023 ·Australian Dental Journal ·Shahrukh Khan, Pei‐Jer Chen, LA Crocombe, (unknown), (unknown), John J. McNeil, Robyn L. Woods, Rory Wolfe, Rosanne Freak‐Poli, Carlene Britt, Danijela Gašević	3
6	Age-based factors modulating the required thyroxine dose to achieve thyrotropin suppression in intermediate-and high-risk papillary thyroid cancer 2023 ·Frontiers in Endocrinology ·(unknown), (unknown), (unknown), (unknown), Pei‐Jer Chen, Mian Liu, Dengjie Ouyang, (unknown), (unknown), (unknown), Yaxin Zhao, Shi Chang, Peng Huang	3
7	Low Hepatitis B Core–Related Antigen Levels Correlate Higher Spontaneous Seroclearance of Hepatitis B Surface Antigen in Chronic Hepatitis B Patients With High Hepatitis B Surface Antigen Levels 2023 ·Gastroenterology ·Tai‐Chung Tseng, (unknown), Chun‐Jen Liu, Chun‐Ming Hong, Tung‐Hung Su, Hung‐Chih Yang, Wanting Yang, Chen‐Hua Liu, Pei‐Jer Chen, Jia‐Horng Kao	13
8	Hepatitis B Virus DNA Integration Drives Carcinogenesis and Provides a New Biomarker for HBV-related HCC 2023 ·Cellular and Molecular Gastroenterology and Hepatology ·Shiou‐Hwei Yeh, (unknown), (unknown), Ming‐Chih Ho, (unknown), (unknown), Pei‐Jer Chen	44
9	Body weight increase and metabolic derangements after tenofovir disoproxil fumarate switch to tenofovir alafenamide in patients with chronic hepatitis B 2023 ·Alimentary Pharmacology & Therapeutics ·Pin‐Nan Cheng, (unknown), (unknown), Hsing‐Tao Kuo, Pei‐Lun Lee, Ming‐Lung Yu, Yen‐Cheng Chiu, Hung‐Chih Chiu, Shih‐Chieh Chien, Pei‐Jer Chen, Chun‐Jen Liu	8
10	Evolution of estimated glomerular filtration rate in human immunodeficiency virus and hepatitis C virus‐coinfected patients receiving sofosbuvir‐based direct‐acting antivirals and antiretroviral therapy 2021 ·Journal of Viral Hepatitis ·Chen‐Hua Liu, Hsin‐Yun Sun, Szu‐Min Hsieh, Wen‐Chun Liu, (unknown), Chun‐Jen Liu, Tung‐Hung Su, Tai‐Chung Tseng, Pei‐Jer Chen, Chien‐Ching Hung, Jia‐Horng Kao	6
11	Drug Resistance Profile and Clinical Features for Hepatitis C Patients Experiencing DAA Failure in Taiwan 2021 ·Viruses ·Chun‐Ming Hong, (unknown), Chun‐Jen Liu, (unknown), Shiou‐Hwei Yeh, Hung‐Chih Yang, Jia‐Horng Kao, Shih–Jer Hsu, Yi‐Hsiang Huang, Sheng‐Shun Yang, Hsing‐Tao Kuo, Pin‐Nan Cheng, Ming‐Lung Yu, Pei‐Jer Chen	1
12	Complement C1q mediates the expansion of periportal hepatic progenitor cells in senescence-associated inflammatory liver 2020 ·Proceedings of the National Academy of Sciences ·(unknown), (unknown), Kun‐Huei Yeh, Yung‐Ming Jeng, (unknown), Li‐Ling Wu, (unknown), Hsuan‐Cheng Huang, Chia‐Lang Hsu, Pei‐Jer Chen, Shiou-Hwei Yeh, Ding‐Shinn Chen	13
13	A Phase I/II Multicenter Study of Single-Agent Foretinib as First-Line Therapy in Patients with Advanced Hepatocellular Carcinoma 2016 ·Clinical Cancer Research ·Thomas Yau, Riccardo Lencioni, Wattana Sukeepaisarnjaroen, Yee Chao, Chia-Jui Yen, (unknown), Pei‐Jer Chen, (unknown), (unknown), Donna S. Cox, Robert Gagnon, Yuan Liu, (unknown), Diptee Kulkarni, Howard Kallender, Lone H. Ottesen, Ronnie T.P. Poon, Donald P. Bottaro	58
14	Evaluation of the protective effects of curcuminoid (curcumin and bisdemethoxycurcumin)-loaded liposomes against bone turnover in a cell-based model of osteoarthritis 2015 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), Pei‐Jer Chen, (unknown), (unknown), (unknown)	10
15	Comparison of Abbott RealTime HCV Genotype II with Versant Line Probe Assay 2.0 for Hepatitis C Virus Genotyping 2015 ·Journal of Clinical Microbiology ·Chen‐Hua Liu, Cheng‐Chao Liang, Chun‐Jen Liu, Chih‐Lin Lin, Tung‐Hung Su, Hung‐Chih Yang, Pei‐Jer Chen, Ding‐Shinn Chen, Jia‐Horng Kao	59
16	Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriers 2014 ·Gut ·Tai‐Chung Tseng, Chun‐Jen Liu, Hung‐Chih Yang, Chi‐Ling Chen, Wanting Yang, (unknown), Stephanie Fang–Tzu Kuo, (unknown), Tung‐Hung Su, Chia‐Chi Wang, Chen‐Hua Liu, Pei‐Jer Chen, Ding‐Shinn Chen, Jia‐Horng Kao	84
17	SC-60, a Dimer-Based Sorafenib Derivative, Shows a Better Anti–Hepatocellular Carcinoma Effect than Sorafenib in a Preclinical Hepatocellular Carcinoma Model 2013 ·Molecular Cancer Therapeutics ·Wei‐Tien Tai, Chung-Wai Shiau, (unknown), Yao-Li Chen, Pei‐Yi Chu, Jui-Wen Huang, (unknown), (unknown), Pei‐Jer Chen, Kuen‐Feng Chen	7
18	FINAL RESULTS OF ENABLE 1, A PHASE 3, MULTICENTER STUDY OF ELTROMBOPAG AS AN ADJUNCT FOR ANTIVIRAL TREATMENT OF HEPATITIS C VIRUS-RELATED CHRONIC LIVER DISEASE ASSOCIATED WITH THROMBOCYTOPENIA 2011 ·UCL Discovery (University College London) ·Nezam H. Afdhal, Geoffrey Dusheiko, Edoardo G. Giannini, Pei‐Jer Chen, Kwang‐Hyub Han, (unknown), M. Rodríguez‐Torres, Sorin Rugină, Eric Lawitz, (unknown), (unknown), F. Poordad, (unknown), Andrés Brainsky, James Geib, (unknown), Rita Patwardhan, (unknown), Dickens Theodore	12
19	Nomograms for Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Virus Infection 2010 ·Journal of Clinical Oncology ·Hwai‐I Yang, Morris Sherman, Jun Su, Pei‐Jer Chen, Yun‐Fan Liaw, Uchenna H. Iloeje, Chien‐Jen Chen	210
20	MGM volume 59 issue 395 Cover and Front matter 1995 ·Mineralogical Magazine ·(unknown), (unknown), Pei‐Jer Chen, Susana García‐Gutiérrez, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact